𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Derivatives of Flavonepenthone: Kappa Opioid Receptor Selectivity in an N-Methylmorphinan

✍ Scribed by Fernando Martinez Bermejo; Stephen M. Husbands; John W. Lewis

Publisher
John Wiley and Sons
Year
1999
Tongue
German
Weight
98 KB
Volume
82
Category
Article
ISSN
0018-019X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Kappa-opioid receptor agonists increase
Kappa-opioid receptor agonists increase locomotor activity in the monoamine-depleted rat model of parkinsonism
✍ Neill R. Hughes; Alexander T. McKnight; Geoffrey N. Woodruff; Michael P. Hill; A 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 607 KB

## Abstract Excessive glutamate transmission in the basal ganglia is a major factor in the neural mechanisms underlying parkinsonian akinesia. Activation of K opioid receptors causes a presynaptic reduction in glutamate release. K opioid receptors are concentrated in those regions of the basal gang

Repeated administration of the selective
Repeated administration of the selective kappa-opioid receptor agonist U-69593 increases stimulated dopamine extracellular levels in the rat nucleus accumbens
✍ José Antonio Fuentealba; Katia Gysling; Karin Magendzo; María Estela Andrés 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

Reinforcing properties of drugs of abuse are reduced by the coadministration of kappa opioid receptor (KOR) agonists. This effect is related to the inhibition of dopamine (DA) release in the nucleus accumbens (NAc) produced by the acute administration of KOR agonists. The present study was undertake

Design and synthesis of 10-oxo derivativ
Design and synthesis of 10-oxo derivative of N-cyclopropylmethyl (−)-6β-acetylthiodihydro-normorphine, a potentially κ-selective opioid receptor ligand
✍ Takeshi Sagara; Sawako Ozawa; Emi Kushiyama; Katsuo Koike; Issei Takayanagi; Ken 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 227 KB

The design and synthesis of 10-oxo derivative of N-cyclopropylmethyl-(-)-613-acetylthio dihydronormorphine (4) are described. The result of pharmacological assays indicate that compound 4 acts as a tt-opioid receptor antagonist and K-opioid receptor agonist which is suggested to be more potent analg